Calcitonin gene‑related peptide reduces Porphyromonas gingivalis LPS‑induced TNF‑α release and apoptosis in osteoblasts

Zhou,Yan; Zhang,Huiyu; Zhang,Gang; He,Yong; Zhang,Ping; Sun,Ziqi; Gao,Yuxia; Tan,Yinghui

doi:10.3892/mmr.2017.8205

Calcitonin gene‑related peptide reduces Porphyromonas gingivalis LPS‑induced TNF‑α release and apoptosis in osteoblasts

Authors:
- Yan Zhou
- Huiyu Zhang
- Gang Zhang
- Yong He
- Ping Zhang
- Ziqi Sun
- Yuxia Gao
- Yinghui Tan
View Affiliations

Affiliations: Department of Oral and Maxillofacial Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, P.R. China, Department of Stomatology, General Hospital of Chengdu Military Region of PLA, Chengdu, Sichuan 610083, P.R. China, Jiebao Biotechnology, Wuhan, Hubei 430012, P.R. China
Published online on: December 6, 2017 https://doi.org/10.3892/mmr.2017.8205
Pages: 3246-3254

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Periodontal diseases comprise mixed bacterial infections mainly caused by Gram‑negative anaerobic bacteria. Lipopolysaccharides (LPS) are important virulence factors and periodontal pathogens, which change local cytokine levels and promote osteoblast apoptosis, thereby leading to an imbalance in bone remodeling mechanisms and accelerating bone loss. Calcitonin gene‑related peptide (CGRP) is a vasoactive neuropeptide that is released from sensory nerves and has a positive effect on osteoblast proliferation and differentiation. In addition, this small molecule peptide is an important immune regulator in the inflammatory response. The aim of the present study was to assess the in vitro effects of CGRP on Porphyromonas gingivalis (Pg)LPS‑induced osteoblast apoptosis. Osteoblast cultures were stimulated either with various concentrations of PgLPS (0, 25, 50, 100, 500 and 1,000 ng/ml) for 48 h or with 500 ng/ml PgLPS for various lengths of time (0, 6, 12, 24, 48 and 72 h). The PgLPS‑stimulated cells were pretreated with different concentrations of CGRP (0, 1, 10, 100 and 1,000 nM) and cell viability and apoptotic rates were measured by Cell Counting kit‑8 assays and flow cytometry, respectively. CGRP, cleaved (c)‑Caspase‑8 and c‑Caspase‑3 protein expression levels were analyzed by western blotting. Changes in cytokine expression levels, which included tumor necrosis factor (TNF)‑α, interleukin (IL)‑1β, IL‑6, monocyte chemotactic protein (MCP)‑1 and MCP‑2, were measured by ELISA. PgLPS was demonstrated to inhibit osteoblast viability and promote apoptosis in a time‑ and concentration‑dependent manner. CGRP expression was revealed to reduce PgLPS‑induced cytostatic activity and apoptosis in osteoblasts. CGRP also suppressed the PgLPS‑induced release of TNF‑α and inhibited the activation of c‑Caspase‑3 and c‑Caspase‑8, thus preventing apoptosis in osteoblasts. CGRP may be an important neuropeptide in bone remodeling and may reduce osteoblast apoptosis in inflammatory conditions. These results may provide a solid foundation for CGRP to serve as a new target for the treatment of periodontitis.

View Figures

View References

1	Boyce BF, Rosenberg E, de Papp AE and Duong LT: The osteoclast, bone remodelling and treatment of metabolic bone disease. Eur J Clin Invest. 42:1332–1341. 2012. View Article : Google Scholar : PubMed/NCBI
2	Di Benedetto A, Gigante I, Colucci S and Grano M: Periodontal disease: Linking the primary inflammation to bone loss. Clin Dev Immunol. 2013:5037542013. View Article : Google Scholar : PubMed/NCBI
3	Song B, Zhou T, Yang WL, Liu J and Shao LQ: Programmed cell death in periodontitis: Recent advances and future perspectives. Oral Dis. 23:609–619. 2017. View Article : Google Scholar : PubMed/NCBI
4	Nakao J, Fujii Y, Kusuyama J, Bandow K, Kakimoto K, Ohnishi T and Matsuguchi T: Low-intensity pulsed ultrasound (LIPUS) inhibits LPS-induced inflammatory responses of osteoblasts through TLR4-MyD88 dissociation. Bone. 58:17–25. 2014. View Article : Google Scholar : PubMed/NCBI
5	Ossola CA, Surkin PN, Pugnaloni A, Mohn CE, Elverdin JC and Fernandez-Solari J: Long-term treatment with methanandamide attenuates LPS-induced periodontitis in rats. Inflamm Res. 61:941–948. 2012. View Article : Google Scholar : PubMed/NCBI
6	Bandow K, Maeda A, Kakimoto K, Kusuyama J, Shamoto M, Ohnishi T and Matsuguchi T: Molecular mechanisms of the inhibitory effect of lipopolysaccharide (LPS) on osteoblast differentiation. Biochem Biophys Res Commun. 402:755–761. 2010. View Article : Google Scholar : PubMed/NCBI
7	Kadono H, Kido J, Kataoka M, Yamauchi N and Nagata T: Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis. Infect Immun. 67:2841–2846. 1999.PubMed/NCBI
8	Kato H, Taguchi Y, Tominaga K, Umeda M and Tanaka A: Porphyromonas gingivalis LPS inhibits osteoblastic differentiation and promotes pro-inflammatory cytokine production in human periodontal ligament stem cells. Arch Oral Biol. 59:167–175. 2014. View Article : Google Scholar : PubMed/NCBI
9	Li Y, Shibata Y, Zhang L, Kuboyama N and Abiko Y: Periodontal pathogen aggregatibacter actinomycetemcomitans LPS induces mitochondria-dependent-apoptosis in human placental trophoblasts. Placenta. 32:11–19. 2011. View Article : Google Scholar : PubMed/NCBI
10	Thammasitboon K, Goldring SR and Boch JA: Role of macrophages in LPS-induced osteoblast and PDL cell apoptosis. Bone. 38:845–852. 2006. View Article : Google Scholar : PubMed/NCBI
11	Melvin KE, Miller HH and Tashjian AH Jr: Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay. N Engl J Med. 285:1115–1120. 1971. View Article : Google Scholar : PubMed/NCBI
12	Broad PM, Symes AJ, Thakker RV and Craig RK: Structure and methylation of the human calcitonin/alpha-CGRP gene. Nucleic Acids Res. 17:6999–7011. 1989. View Article : Google Scholar : PubMed/NCBI
13	Baillie LD, Schmidhammer H and Mulligan SJ: Peripheral mu-opioid receptor mediated inhibition of calcium signaling and action potential-evoked calcium fluorescent transients in primary afferent CGRP nociceptive terminals. Neuropharmacology. 93:267–273. 2015. View Article : Google Scholar : PubMed/NCBI
14	Pereira RT, Costa LS, Oliveira IR, Araújo JC, Aerts M, Vigliano FA and Rosa PV: Relative distribution of gastrin-, CCK-8-, NPY- and CGRP-immunoreactive cells in the digestive tract of dorado (Salminus brasiliensis). Tissue Cell. 47:123–131. 2015. View Article : Google Scholar : PubMed/NCBI
15	Uddman R, Luts A and Sundler F: Occurrence and distribution of calcitonin gene-related peptide in the mammalian respiratory tract and middle ear. Cell Tissue Res. 241:551–555. 1985. View Article : Google Scholar : PubMed/NCBI
16	Sun T, Guo Z, Liu CJ, Li MR, Li TP, Wang X and Yuan DJ: Preservation of CGRP in myocardium attenuates development of cardiac dysfunction in diabetic rats. Int J Cardiol. 220:226–234. 2016. View Article : Google Scholar : PubMed/NCBI
17	He H, Chai J, Zhang S, Ding L, Yan P, Du W and Yang Z: CGRP may regulate bone metabolism through stimulating osteoblast differentiation and inhibiting osteoclast formation. Mol Med Rep. 13:3977–3984. 2016. View Article : Google Scholar : PubMed/NCBI
18	Tian G, Zhang G and Tan YH: Calcitonin gene-related peptide stimulates BMP-2 expression and the differentiation of human osteoblast-like cells in vitro. Acta Pharmacol Sin. 34:1467–1474. 2013. View Article : Google Scholar : PubMed/NCBI
19	Holzmann B: Modulation of immune responses by the neuropeptide CGRP. Amino Acids. 45:1–7. 2013. View Article : Google Scholar : PubMed/NCBI
20	Holzmann B: Antiinflammatory activities of CGRP modulating innate immune responses in health and disease. Curr Protein Pept Sci. 14:268–274. 2013. View Article : Google Scholar : PubMed/NCBI
21	Streilein JW: Ocular immune privilege: Therapeutic opportunities from an experiment of nature. Nat Rev Immunol. 3:879–889. 2003. View Article : Google Scholar : PubMed/NCBI
22	Carucci JA, Ignatius R, Wei Y, Cypess AM, Schaer DA, Pope M, Steinman RM and Mojsov S: Calcitonin gene-related peptide decreases expression of HLA-DR and CD86 by human dendritic cells and dampens dendritic cell-driven T cell-proliferative responses via the type I calcitonin gene-related peptide receptor. J Immunol. 164:3494–3499. 2000. View Article : Google Scholar : PubMed/NCBI
23	Harzenetter MD, Novotny AR, Gais P, Molina CA, Altmayr F and Holzmann B: Negative regulation of TLR responses by the neuropeptide CGRP is mediated by the transcriptional repressor ICER. J Immunol. 179:607–615. 2007. View Article : Google Scholar : PubMed/NCBI
24	Nagata S: Apoptosis by death factor. Cell. 88:355–365. 1997. View Article : Google Scholar : PubMed/NCBI
25	Kroeger I, Erhardt A, Abt D, Fischer M, Biburger M, Rau T, Neuhuber WL and Tiegs G: The neuropeptide calcitonin gene-related peptide (CGRP) prevents inflammatory liver injury in mice. J Hepatol. 51:342–353. 2009. View Article : Google Scholar : PubMed/NCBI
26	Orriss IR, Hajjawi MO, Huesa C, MacRae VE and Arnett TR: Optimisation of the differing conditions required for bone formation in vitro by primary osteoblasts from mice and rats. Int J Mol Med. 34:1201–1208. 2014. View Article : Google Scholar : PubMed/NCBI
27	DeLeon-Pennell KY, de Castro Brás LE, Iyer RP, Bratton DR, Jin YF, Ripplinger CM and Lindsey ML: P. gingivalis lipopolysaccharide intensifies inflammation post-myocardial infarction through matrix metalloproteinase-9. J Mol Cell Cardiol. 76:218–226. 2014. View Article : Google Scholar : PubMed/NCBI
28	Ding PH, Darveau RP, Wang CY and Jin L: 3LPS-binding protein and its interactions with P. gingivalis LPS modulate pro-inflammatory response and toll-like receptor signaling in human oral keratinocytes. PLoS One. 12:e01732232017. View Article : Google Scholar : PubMed/NCBI
29	Wu X, Feng X, He Y, et al: IL-4 administration exerts preventive effects via suppression of underlying inflammation and TNF-α-induced apoptosis in steroid-induced osteonecrosis. Osteoporos Int. 27:1827–1837. 2016. View Article : Google Scholar : PubMed/NCBI
30	Liang W, Zhuo X, Tang Z, Wei X and Li B: Calcitonin gene-related peptide stimulates proliferation and osteogenic differentiation of osteoporotic rat-derived bone mesenchymal stem cells. Mol Cell Biochem. 402:101–110. 2015. View Article : Google Scholar : PubMed/NCBI
31	Ma W, Zhang X, Shi S and Zhang Y: Neuropeptides stimulate human osteoblast activity and promote gap junctional intercellular communication. Neuropeptides. 47:179–186. 2013. View Article : Google Scholar : PubMed/NCBI
32	Millet I and Vignery A: The neuropeptide calcitonin gene-related peptide inhibits TNF-alpha but poorly induces IL-6 production by fetal rat osteoblasts. Cytokine. 9:999–1007. 1997. View Article : Google Scholar : PubMed/NCBI
33	Redlich K and Smolen JS: Inflammatory bone loss: Pathogenesis and therapeutic intervention. Nat Rev Drug Discov. 11:234–250. 2012. View Article : Google Scholar : PubMed/NCBI
34	Guo C, Yuan L, Wang JG, Wang F, Yang XK, Zhang FH, Song JL, Ma XY, Cheng Q and Song GH: Lipopolysaccharide (LPS) induces the apoptosis and inhibits osteoblast differentiation through JNK pathway in MC3T3-E1 cells. Inflammation. 37:621–631. 2014. View Article : Google Scholar : PubMed/NCBI
35	Favaloro B, Allocati N, Graziano V, Di Ilio C and De Laurenzi V: Role of apoptosis in disease. Aging (Albany NY). 4:330–349. 2012. View Article : Google Scholar : PubMed/NCBI
36	Meshcheryakova A, Mechtcheriakova D and Pietschmann P: Sphingosine 1-phosphate signaling in bone remodeling: Multifaceted roles and therapeutic potential. Expert Opin Ther Targets. 21:725–737. 2017. View Article : Google Scholar : PubMed/NCBI
37	Kesavalu L, Sathishkumar S, Bakthavatchalu V, Matthews C, Dawson D, Steffen M and Ebersole JL: Rat model of polymicrobial infection, immunity and alveolar bone resorption in periodontal disease. Infect Immun. 75:1704–1712. 2007. View Article : Google Scholar : PubMed/NCBI
38	Bai Y, Wei Y, Wu L, Wei J, Wang X and Bai Y: C/EBP β mediates endoplasmic reticulum stress regulated inflammatory response and extracellular matrix degradation in LPS-stimulated human periodontal ligament cells. Int J Mol Sci. 17:3852016. View Article : Google Scholar : PubMed/NCBI
39	Jaedicke KM, Preshaw PM and Taylor JJ: Salivary cytokines as biomarkers of periodontal diseases. Periodontol 2000. 70:164–183. 2016. View Article : Google Scholar : PubMed/NCBI
40	Toyman U, Tuter G, Kurtis B, Kıvrak E, Bozkurt Ş, Yücel AA and Serdar M: Evaluation of gingival crevicular fluid levels of tissue plasminogen activator, plasminogen activator inhibitor 2, matrix metalloproteinase-3 and interleukin 1-β in patients with different periodontal diseases. J Periodontal Res. 50:44–51. 2015. View Article : Google Scholar : PubMed/NCBI
41	Hou GQ, Guo C, Song GH, Fang N, Fan WJ, Chen XD, Yuan L and Wang ZQ: Lipopolysaccharide (LPS) promotes osteoclast differentiation and activation by enhancing the MAPK pathway and COX-2 expression in RAW264.7 cells. Int J Mol Med. 32:503–510. 2013. View Article : Google Scholar : PubMed/NCBI
42	Guo C, Wang SL, Xu ST, Wang JG and Song GH: SP600125 reduces lipopolysaccharide-induced apoptosis and restores the early-stage differentiation of osteoblasts inhibited by LPS through the MAPK pathway in MC3T3-E1 cells. Int J Mol Med. 35:1427–1434. 2015. View Article : Google Scholar : PubMed/NCBI
43	Kırzıoğlu FY, Tözüm Bulut M, Doğan B, Fentoğlu Ö, Özmen Ö, Çarsancaklı SA, Ergün AG, Özdem M and Orhan H: Anti-inflammatory effect of rosuvastatin decreases alveolar bone loss in experimental periodontitis. J Oral Sci. 59:247–255. 2017. View Article : Google Scholar : PubMed/NCBI
44	Yao Z, Lei W, Duan R, Li Y, Luo L and Boyce BF: RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors. J Biol Chem. 292:10169–10179. 2017. View Article : Google Scholar : PubMed/NCBI
45	Tzach-Nahman R, Mizraji G, Shapira L, Nussbaum G and Wilensky A: Oral infection with porphyromonas gingivalis induces peri-implantitis in a murine model: Evaluation of bone loss and the local inflammatory response. J Clin Periodontol. 44:739–748. 2017. View Article : Google Scholar : PubMed/NCBI
46	Al-Daghri NM, Aziz I, Yakout S, Aljohani NJ, Al-Saleh Y, Amer OE, Sheshah E, Younis GZ and Al-Badr FB: Inflammation as a contributing factor among postmenopausal Saudi women with osteoporosis. Medicine (Baltimore). 96:e57802017. View Article : Google Scholar : PubMed/NCBI
47	Chen YL, Qiao YC, Xu Y, Ling W, Pan YH, Huang YC, Geng LJ, Zhao HL and Zhang XX: Serum TNF-α concentrations in type 2 diabetes mellitus patients and diabetic nephropathy patients: A systematic review and meta-analysis. Immunol Lett. 186:52–58. 2017. View Article : Google Scholar : PubMed/NCBI
48	Wang C, Yu X, Yan Y, Yang W, Zhang S, Xiang Y, Zhang J and Wang W: Tumor necrosis factor-alpha: a key contributor to intervertebral disc degeneration. Acta Biochim Biophys Sin (Shanghai). 49:1–13. 2017. View Article : Google Scholar : PubMed/NCBI
49	Centrella M, McCarthy TL and Canalis E: Tumor necrosis factor-alpha inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on deoxyribonucleic acid synthesis in osteoblast-enriched bone cell cultures. Endocrinology. 123:1442–1448. 1988. View Article : Google Scholar : PubMed/NCBI
50	Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP and Teitelbaum SL: TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest. 106:1481–1488. 2000. View Article : Google Scholar : PubMed/NCBI
51	Park J, Choi HM, Yang HI, Yoo MC and Kim KS: Increased expression of IL-1 receptors in response to IL-1β may produce more IL-6, IL-8, VEGF and PGE2 in senescent synovial cells induced in vitro than in presenescent cells. Rheumatol Int. 32:2005–2010. 2012. View Article : Google Scholar : PubMed/NCBI
52	Santos RS, Macedo RF, Souza EA, Soares RS, Feitosa DS and Sarmento CF: The use of systemic antibiotics in the treatment of refractory periodontitis: A systematic review. J Am Dent Assoc. 147:577–585. 2016. View Article : Google Scholar : PubMed/NCBI